Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
31.70
+0.16 (0.51%)
At close: May 9, 2025, 4:00 PM
31.15
-0.55 (-1.74%)
After-hours: May 9, 2025, 4:07 PM EDT

Supernus Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
115.8569.3375.0593.12203.43288.64
Upgrade
Short-Term Investments
347.74384.28179.82368.21136.25133.89
Upgrade
Cash & Short-Term Investments
463.59453.61254.87461.33339.68422.53
Upgrade
Cash Growth
55.71%77.98%-44.75%35.81%-19.61%21.74%
Upgrade
Receivables
145.64142.08144.16165.5148.93140.88
Upgrade
Inventory
49.4254.2977.4191.5485.9648.33
Upgrade
Prepaid Expenses
28.9336.0916.6815.7827.0218.68
Upgrade
Total Current Assets
687.58686.07493.11734.15601.59630.42
Upgrade
Property, Plant & Equipment
34.0636.0242.5244.0852.3258.06
Upgrade
Long-Term Investments
--16.6293.9119.17350.36
Upgrade
Goodwill
117.02117.02117.02117.02117.5277.91
Upgrade
Other Intangible Assets
502.13521.91599.89702.46784.69364.34
Upgrade
Other Long-Term Assets
6.57.058.5110.913.8723.02
Upgrade
Total Assets
1,3471,3681,2781,7031,6891,504
Upgrade
Accounts Payable
7.074.591.9610.549.336.15
Upgrade
Accrued Expenses
184.09180.21166.26185.67199.47165.62
Upgrade
Current Portion of Long-Term Debt
---407.977.245.32
Upgrade
Current Portion of Leases
5.946.898.336.796.487.52
Upgrade
Other Current Liabilities
84.67100.72113.6476.9992.8660.5
Upgrade
Total Current Liabilities
281.77292.4290.2687.96315.38245.11
Upgrade
Long-Term Debt
----385.23375.16
Upgrade
Long-Term Leases
26.3727.3833.23641.348.81
Upgrade
Long-Term Deferred Tax Liabilities
0.984.9624.9649.8185.3635.22
Upgrade
Other Long-Term Liabilities
7.467.67.842.5446.0454.95
Upgrade
Total Liabilities
316.59332.34356.16816.3873.3759.24
Upgrade
Common Stock
0.060.060.060.050.050.05
Upgrade
Additional Paid-In Capital
486.21479.44439.49408.12434.34409.33
Upgrade
Retained Earnings
544.6556.43482.56481.25379.92326.5
Upgrade
Comprehensive Income & Other
-0.16-0.19-0.59-3.211.548.98
Upgrade
Shareholders' Equity
1,0311,036921.52886.2815.85744.86
Upgrade
Total Liabilities & Equity
1,3471,3681,2781,7031,6891,504
Upgrade
Total Debt
32.3134.2741.53450.76440.25436.82
Upgrade
Net Cash (Debt)
431.29419.34229.96104.4718.6336.08
Upgrade
Net Cash Growth
61.37%82.35%120.12%461.74%-94.47%-37.52%
Upgrade
Net Cash Per Share
7.707.494.141.690.346.26
Upgrade
Filing Date Shares Outstanding
55.9955.8154.7354.3853.3952.92
Upgrade
Total Common Shares Outstanding
55.9955.7454.7254.2553.2652.87
Upgrade
Working Capital
405.81393.67202.9246.19286.21385.31
Upgrade
Book Value Per Share
18.4118.5816.8416.3315.3214.09
Upgrade
Tangible Book Value
411.56396.8204.6166.72-86.36302.61
Upgrade
Tangible Book Value Per Share
7.357.123.741.23-1.625.72
Upgrade
Machinery
14.8714.4814.0313.1114.2314.64
Upgrade
Construction In Progress
---0.210.03-
Upgrade
Leasehold Improvements
14.0214.0214.0214.0214.3715.18
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q